CLINDAMYCIN 1% / NIACINAMIDE 4%- clindamycin 1% / niacinamide 4% gel 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CLINDAMYCIN 1% / NIACINAMIDE 4%

Directions for use

ds

Sincerus Florida, LLC. Adverse reactions

X

Active, inactive

SAS

NDC 72934- 1051-2 CLINDAMYCIN PHOSPHATE USP 1% / NIACINAMIDE USP 4%. Gel 30gm

zc

CLINDAMYCIN 1% / NIACINAMIDE 4% 
clindamycin 1% / niacinamide 4% gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1051
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
CLINDAMYCIN PHOSPHATE (UNII: EH6D7113I8) (CLINDAMYCIN - UNII:3U02EL437C) CLINDAMYCIN PHOSPHATE1 g  in 100 g
Product Characteristics
Colorwhite (Clear gel) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-1051-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/10/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/10/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-1051)

Revised: 8/2019
Document Id: 907a0ee6-b91e-58fe-e053-2a95a90a0cb8
Set id: 88786626-1999-7791-e053-2a95a90a91f6
Version: 2
Effective Time: 20190819
 
Sincerus Florida, LLC